{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:13:55Z","timestamp":1786979635638,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,11,10]],"date-time":"2011-11-10T00:00:00Z","timestamp":1320883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00125-011-2365-4","type":"journal-article","created":{"date-parts":[[2011,11,9]],"date-time":"2011-11-09T10:47:02Z","timestamp":1320835622000},"page":"404-412","source":"Crossref","is-referenced-by-count":101,"title":["Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice"],"prefix":"10.1007","volume":"55","author":[{"given":"Y.","family":"Takeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Honjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Yanagimachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Sakagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Takiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Abiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. J.","family":"Kieffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Haneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,10]]},"reference":[{"key":"2365_CR1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","volume":"52","author":"AE Butler","year":"2003","unstructured":"Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) \u03b2-Cell deficit and increased \u03b2-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102\u2013110","journal-title":"Diabetes"},{"key":"2365_CR2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/414792a","volume":"414","author":"D Mathis","year":"2001","unstructured":"Mathis D, Vence L, Benoist C (2001) \u03b2-cell death during progression to diabetes. Nature 414:792\u2013798","journal-title":"Nature"},{"key":"2365_CR3","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2337\/diabetes.49.6.975","volume":"49","author":"D Tripathy","year":"2000","unstructured":"Tripathy D, Carlsson M, Almgren P et al (2000) Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes 49:975\u2013980","journal-title":"Diabetes"},{"key":"2365_CR4","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.metabol.2004.02.012","volume":"53","author":"M Fukushima","year":"2004","unstructured":"Fukushima M, Usami M, Ikeda M et al (2004) Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism 53:831\u2013835","journal-title":"Metabolism"},{"key":"2365_CR5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","volume":"3","author":"DJ Drucker","year":"2006","unstructured":"Drucker DJ (2006) The biology of incretin hormones. Cell Metab 3:153\u2013165","journal-title":"Cell Metab"},{"key":"2365_CR6","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","volume":"132","author":"LL Baggio","year":"2007","unstructured":"Baggio LL, Drucker DJ (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132:2131\u20132157","journal-title":"Gastroenterology"},{"key":"2365_CR7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/diabetes.52.3.741","volume":"52","author":"JA Pospisilik","year":"2003","unstructured":"Pospisilik JA, Martin J, Doty T et al (2003) Dipeptidyl peptidase IV inhibitor treatment stimulates \u03b2-cell survival and islet neogenesis in streptozotocin-induced diabetic rats. Diabetes 52:741\u2013750","journal-title":"Diabetes"},{"key":"2365_CR8","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.2337\/db05-1602","volume":"55","author":"J Mu","year":"2006","unstructured":"Mu J, Woods J, Zhou YP et al (2006) Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic \u03b2-cell mass and function in a rodent model of type 2 diabetes. Diabetes 55:1695\u20131704","journal-title":"Diabetes"},{"key":"2365_CR9","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2337\/db07-1639","volume":"57","author":"SJ Kim","year":"2008","unstructured":"Kim SJ, Nian C, Doudet DJ, Mclntosh CH (2008) Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice. Diabetes 57:1331\u20131339","journal-title":"Diabetes"},{"key":"2365_CR10","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2337\/diabetes.51.5.1461","volume":"51","author":"B Sudre","year":"2002","unstructured":"Sudre B, Broqua P, White RB et al (2002) Chronic inhibition of circulating dipeptidyl peptidase IV by FE 999011 delays the occurrence of diabetes in male zucker diabetic fatty rats. Diabetes 51:1461\u20131469","journal-title":"Diabetes"},{"key":"2365_CR11","first-page":"536","volume":"50","author":"T Szkudelski","year":"2001","unstructured":"Szkudelski T (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50:536\u2013546","journal-title":"Physiol Res"},{"key":"2365_CR12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00125-007-0886-7","volume":"51","author":"S Lenzen","year":"2008","unstructured":"Lenzen S (2008) The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51:216\u2013226","journal-title":"Diabetologia"},{"key":"2365_CR13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1681\/ASN.2004080648","volume":"16","author":"MD Breyer","year":"2005","unstructured":"Breyer MD, B\u00f6ttinger E, Brosius FC 3rd et al (2005) Mouse models of diabetic nephropathy. J Am Soc Nephrol 16:27\u201345","journal-title":"J Am Soc Nephrol"},{"key":"2365_CR14","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1053\/j.gastro.2010.01.049","volume":"138","author":"Y Fujita","year":"2010","unstructured":"Fujita Y, Wideman RD, Asadi A et al (2010) Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet \u03b1-cells and promotes insulin secretion. Gastroenterology 138:1966\u20131975","journal-title":"Gastroenterology"},{"key":"2365_CR15","doi-asserted-by":"crossref","first-page":"E936","DOI":"10.1152\/ajpendo.90768.2008","volume":"296","author":"MJ Riedel","year":"2008","unstructured":"Riedel MJ, Lee CW, Kieffer TJ (2008) Engineered glucagon-like peptide-1-producing hepatocytes lower plasma glucose levels in mice. Am J Physiol Endocrinol Metab 296:E936\u2013E944","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2365_CR16","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1172\/JCI106297","volume":"49","author":"RH Unger","year":"1970","unstructured":"Unger RH, Aguilar-Parada E, M\u00fcller WA, Eisentraut AM (1970) Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest 49:837\u2013848","journal-title":"J Clin Invest"},{"key":"2365_CR17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/diab.25.2.136","volume":"25","author":"RH Unger","year":"1976","unstructured":"Unger RH (1976) The Banting Memorial Lecture 1975. Diabetes and the alpha cell. Diabetes 25:136\u2013151","journal-title":"Diabetes"},{"key":"2365_CR18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/BF00281991","volume":"28","author":"RH Unger","year":"1985","unstructured":"Unger RH (1985) Glucagon physiology and pathophysiology in the light of new advances. Diabetologia 28:574\u2013578","journal-title":"Diabetologia"},{"key":"2365_CR19","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2337\/diacare.15.3.430","volume":"15","author":"A Consoli","year":"1992","unstructured":"Consoli A (1992) Role of liver in pathophysiology of NIDDM. Diabetes Care 15:430\u2013441","journal-title":"Diabetes Care"},{"key":"2365_CR20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2337\/diabetes.36.3.274","volume":"36","author":"AD Baron","year":"1987","unstructured":"Baron AD, Schaeffer L, Shragg P, Kolterman OG (1987) Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type 2 diabetics. Diabetes 36:274\u2013283","journal-title":"Diabetes"},{"key":"2365_CR21","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00042871-200409000-00030","volume":"52","author":"A Basu","year":"2004","unstructured":"Basu A, Shah P, Nielsen M, Basu R, Rizza RA (2004) Effects of type 2 diabetes on the regulation of hepatic glucose metabolism. J Investig Med 52:366\u2013374","journal-title":"J Investig Med"},{"key":"2365_CR22","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2337\/diabetes.49.8.1367","volume":"49","author":"A Gastaldelli","year":"2000","unstructured":"Gastaldelli A, Baldi S, Pettiti M et al (2000) Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 49:1367\u20131373","journal-title":"Diabetes"},{"key":"2365_CR23","doi-asserted-by":"crossref","first-page":"E415","DOI":"10.1152\/ajpendo.90887.2008","volume":"296","author":"S Ali","year":"2009","unstructured":"Ali S, Drucker DJ (2009) Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes. Am J Physiol Endocrinol Metab 296:E415\u2013E421","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2365_CR24","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1007\/s00125-005-1878-0","volume":"48","author":"BE Dunning","year":"2005","unstructured":"Dunning BE, Foley JE, Ahr\u00e9n B (2005) Alpha cell function in health and disease: influence of glucagon-like peptide-1. Diabetologia 48:1700\u20131713","journal-title":"Diabetologia"},{"key":"2365_CR25","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1210\/en.2011-0286","volume":"152","author":"A Waget","year":"2011","unstructured":"Waget A, Cabou C, Masseboeuf M et al (2011) Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice. Endocrinology 152:3018\u20133029","journal-title":"Endocrinology"},{"key":"2365_CR26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1677\/joe.0.1740233","volume":"174","author":"A Trumper","year":"2002","unstructured":"Trumper A, Trumper K, Horsch D (2002) Mechanisms of mitogenic and anti-apoptotic signaling by glucose dependent insulinotropic polypeptide in \u03b2(INS-1)-cells. J Endocrinol 174:233\u2013246","journal-title":"J Endocrinol"},{"key":"2365_CR27","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1210\/en.2002-220897","volume":"144","author":"H Hui","year":"2003","unstructured":"Hui H, Nourparvar A, Zhao X, Perfetti R (2003) Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5\u2032-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase dependent pathway. Endocrinology 144:1444\u20131455","journal-title":"Endocrinology"},{"key":"2365_CR28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1074\/jbc.M209423200","volume":"278","author":"Y Li","year":"2003","unstructured":"Li Y, Hansotia T, Yusta B, Ris F, Halban PA, Drucker DJ (2003) Glucagon-like peptide-1 receptor signaling modulates \u03b2-cell apoptosis. J Biol Chem 278:471\u2013478","journal-title":"J Biol Chem"},{"key":"2365_CR29","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1210\/en.2002-0068","volume":"144","author":"JA Ehses","year":"2003","unstructured":"Ehses JA, Casilla VR, Doty T et al (2003) Glucose-dependent insulinotropic polypeptide promotes \u03b2-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase. Endocrinology 144:4433\u20134445","journal-title":"Endocrinology"},{"key":"2365_CR30","doi-asserted-by":"crossref","first-page":"8938","DOI":"10.1074\/jbc.M310330200","volume":"279","author":"G Kwon","year":"2004","unstructured":"Kwon G, Pappan KL, Marshall CA, Schaffer JE, McDaniel ML (2004) Cyclic AMP dose-dependently prevents palmitate-induced apoptosis by both PKA and cAMP-GEF-dependent pathways in \u03b2-cells. J Biol Chem 279:8938\u20138945","journal-title":"J Biol Chem"},{"key":"2365_CR31","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00125-004-1379-6","volume":"47","author":"J Buteau","year":"2004","unstructured":"Buteau J, El-Assaad W, Rhodes CJ, Rosenberg L, Joly E, Prentki M (2004) Glucagon-like peptide-1 prevents beta cell glucolipotoxicity. Diabetologia 47:806\u2013815","journal-title":"Diabetologia"},{"key":"2365_CR32","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2337\/db07-1214","volume":"57","author":"M Ferdaoussi","year":"2008","unstructured":"Ferdaoussi M, Abdelli S, Yang JY et al (2008) Exendin-4 protects \u03b2-cells from interleukin-1\u03b2-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway. Diabetes 57:1205\u20131215","journal-title":"Diabetes"},{"key":"2365_CR33","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2337\/db09-0063","volume":"58","author":"M Cornu","year":"2009","unstructured":"Cornu M, Yang JY, Jaccard E, Poussin C, Widmann C, Thorens B (2009) Glucagon-like peptide-1 protects \u03b2-cells against apoptosis by increasing the activity of an IGF-2\/IGF-1 receptor autocrine loop. Diabetes 58:1816\u20131825","journal-title":"Diabetes"},{"key":"2365_CR34","doi-asserted-by":"crossref","first-page":"10538","DOI":"10.1074\/jbc.M109.091116","volume":"285","author":"M Cornu","year":"2010","unstructured":"Cornu M, Modi H, Kawamori D, Kulkani RN, Joffraud M, Thorens B (2010) Glucagon-like peptide-1 increases \u03b2-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression. J Biol Chem 285:10538\u201310545","journal-title":"J Biol Chem"},{"key":"2365_CR35","doi-asserted-by":"crossref","first-page":"10764","DOI":"10.1074\/jbc.M809116200","volume":"284","author":"SB Widenmaier","year":"2009","unstructured":"Widenmaier SB, Sampaio AV, Underhill TM, McIntosh CH (2009) Noncanonical activation of Akt\/protein kinase B in \u03b2-cells by the incretin hormone glucose-dependent insulinotropic polypeptide. J Biol Chem 284:10764\u201310773","journal-title":"J Biol Chem"},{"key":"2365_CR36","doi-asserted-by":"crossref","first-page":"22297","DOI":"10.1074\/jbc.M500540200","volume":"280","author":"SJ Kim","year":"2005","unstructured":"Kim SJ, Winter K, Nian C, Tsuneoka M, Koda Y, McIntosh CH (2005) Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic \u03b2-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)\/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression. J Biol Chem 280:22297\u201322307","journal-title":"J Biol Chem"},{"key":"2365_CR37","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF00251826","volume":"24","author":"J Rahier","year":"1983","unstructured":"Rahier J, Goebbels RM, Henquin JC (1983) Cellular composition of the human diabetic pancreas. Diabetologia 24:366\u2013371","journal-title":"Diabetologia"},{"key":"2365_CR38","first-page":"151","volume":"9","author":"A Clark","year":"1988","unstructured":"Clark A, Wells CA, Buley ID et al (1988) Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 9:151\u2013159","journal-title":"Diabetes Res"},{"key":"2365_CR39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s125-002-8248-z","volume":"45","author":"H Sakuraba","year":"2002","unstructured":"Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S (2002) Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type 2 diabetic patients. Diabetologia 45:85\u201396","journal-title":"Diabetologia"},{"key":"2365_CR40","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1210\/jc.2002-020735","volume":"88","author":"KH Yoon","year":"2003","unstructured":"Yoon KH, Ko SH, Cho JH et al (2003) Selevtive \u03b2-cell loss and \u03b1-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88:2300\u20132308","journal-title":"J Clin Endocrinol Metab"},{"key":"2365_CR41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1369\/jhc.6A7024.2006","volume":"55","author":"K Iki","year":"2007","unstructured":"Iki K, Pour PM (2007) Distribution of pancreatic endocrine cells including IAPP-expressing cells in non-diabetic and type 2 diabetic cases. J Histochem Cytochem 55:111\u2013118","journal-title":"J Histochem Cytochem"},{"key":"2365_CR42","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF01219780","volume":"9","author":"V Hoftiezer","year":"1973","unstructured":"Hoftiezer V, Carpenter AM (1973) Comparison of streptozotocin and alloxan-induced diabetes in the rat, including volumetric quantitation of the pancreatic islets. Diabetologia 9:178\u2013184","journal-title":"Diabetologia"},{"key":"2365_CR43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1677\/joe.0.1650093","volume":"165","author":"Z Li","year":"2000","unstructured":"Li Z, Karlsson FA, Sandler S (2000) Islet loss and alpha cell expansion in type 1 diabetes induced by multiple low-dose streptozotocin administration in mice. J Endocrinol 165:93\u201399","journal-title":"J Endocrinol"},{"key":"2365_CR44","doi-asserted-by":"crossref","first-page":"13163","DOI":"10.1073\/pnas.0801059105","volume":"105","author":"H Ellingsgaard","year":"2008","unstructured":"Ellingsgaard H, Ehses JA, Hammar EB et al (2008) Interleukin-6 regulates pancreatic \u03b1-cell mass expansion. Proc Natl Acad Sci USA 105:13163\u201313168","journal-title":"Proc Natl Acad Sci USA"},{"key":"2365_CR45","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1073\/pnas.0237106100","volume":"100","author":"RW Gelling","year":"2003","unstructured":"Gelling RW, Du XQ, Dichmann DS et al (2003) Lower blood glucose, hyperglucagonemia, and pancreatic \u03b1 cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci USA 100:1438\u20131443","journal-title":"Proc Natl Acad Sci USA"},{"key":"2365_CR46","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00125-011-2080-1","volume":"54","author":"AM Hansen","year":"2011","unstructured":"Hansen AM, B\u00f6dvarsdottir TB, Nordestgaard DN et al (2011) Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus\u2014an adaptive response to hyperglycaemia? Diabetologia 54:1379\u20131387","journal-title":"Diabetologia"},{"key":"2365_CR47","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cmet.2009.02.007","volume":"9","author":"D Kawamori","year":"2009","unstructured":"Kawamori D, Kurpad AJ, Hu J et al (2009) Insulin signaling in \u03b1-cells modulates glucagon secretion in vivo. Cell Metab 9:350\u2013361","journal-title":"Cell Metab"},{"key":"2365_CR48","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nature08894","volume":"464","author":"F Thorel","year":"2010","unstructured":"Thorel F, Nepote V, Avril I et al (2010) Conversion of adult pancreatic \u03b1-cells to \u03b2-cells after extreme \u03b2-cell loss. Nature 464:1149\u20131154","journal-title":"Nature"},{"key":"2365_CR49","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.2337\/diabetes.51.11.3229","volume":"51","author":"K Prasadan","year":"2002","unstructured":"Prasadan K, Daume E, Preuett B et al (2002) Glucagon is required for early insulin-positive differentiation in the developing mouse pancreas. Diabetes 51:3229\u20133236","journal-title":"Diabetes"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-011-2365-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-011-2365-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-011-2365-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T07:49:36Z","timestamp":1558597776000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-011-2365-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,10]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["2365"],"URL":"https:\/\/doi.org\/10.1007\/s00125-011-2365-4","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,10]]}}}